Atrial fibrillation; Stroke; Structural heart disease; Left atrial appendage occlusion
Abstract :
[en] Atrial fibrillation (AF) is the most common clinical arrythmia and can be associated with severe thromboembolic complications. For different reasons, a large number of AF patients who would benefit from oral anticoagulation (OAC) are not treated. In case of contra-indications to long-term OAC, left atrial appendage (LAA) closure allows the exclusion of the LAA from the systemic circulation and significantly reduces the thromboembolism risk. Results from large randomized trials show that this technique is non-inferior in terms of efficacy compared to OAC and that it can significantly reduce the rate of haemorrhagic complications. Large-scale registries show promising results in patients with contra-indications to long-term OAC. Clinical trials are under way to define the role and spectrum of LAA occlusion and to optimize post-procedural treatment.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
LEMPEREUR, Mathieu ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Cardiologie interventionnelle
DAVIN, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Cardiologie interventionnelle
DULGHERU, Raluca Elena ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Clinique des valvulopathies - Echocardiographies - Imagerie
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Language :
French
Title :
Fermeture percutanee de l'auricule gauche pour la prevention des complications thrombo-emboliques en cas de fibrillation auriculaire.
Alternative titles :
[en] Percutaneous left atrial appendage occlusion for thromboembolism protection in patients with atrial fibrillation
Publication date :
2019
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
January CT, Wann LS, Alpert JS, et al.- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of Cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol, 2014, 64, e1-76.
Kannel WB, Abbott RD, Savage DD, et al.- Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med, 1982, 306, 1018-1022.
Whitlock RP, Hanif H, Danter M.- Nonpharmacologic approaches to stroke prevention in atrial fibrillation. Can J Cardiol, 2013, 29, S79-86.
Wolf PA, D'Agostino RB, Belanger AJ, et al.- Probability of stroke: a risk profile from the Framingham Study. Stroke, 1991, 22, 312-318.
Lamassa M, Di Carlo A, Pracucci G, et al.- Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke, 2001, 32, 392-398.
Hart RG, Pearce LA, Aguilar MI.- Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146, 857-867.
Ezekowitz MD, Bridgers SL, James KE, et al.-Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med, 1992, 327, 1406-1412.
Nieuwlaat R, Capucci A, Camm AJ, et al.- Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Hear J, 2005, 26, 2422-2434.
Mélon P, Garweg C, Lancellotti P, Piérard L.-Adhésion au traitement anti-thrombotique de la fibrillation auriculaire. Rev Med Liege, 2010, 65, 299-303.
Ogilvie IM, Newton N, Welner SA, et al.- Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med, 2010, 123, 638-645.
Meier B, Blaauw Y, Khattab AA, et al.- EHRA/ EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace, 2014, 16, 1397-1416.
Blackshear JL, Odell JA.- Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg, 1996, 61, 755-759.
Takada T, Yasaka M, Nagatsuka K, et al.- Blood flow in the left atrial appendage and embolic stroke in nonvalvular atrial fibrillation. Eur Neurol, 2001, 46, 148-152.
Frustaci A, Chimenti C, Bellocci F, et al.- Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997, 96, 1180-1184.
Inoue H, Nozawa T, Okumura K, et al.- Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest, 2004, 126, 687-692.
Watson T, Shantsila E, Lip GY.- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet, 2009, 373, 155-166.
Mélon P, Lancellotti P.- Recommandations Europeennes 2010 pour le traitement anti-thrombotique de la fibrillation auriculaire: Nouveaux scores pour l'évaluation des risques d'accident vasculaire cérébral et de saignement. Rev Med Liege, 2010, 65, 580-582.
Kirchhof P, Benussi S, Kotecha D, et al.- 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol, 2017, 70, 50-56.
Lip GYH, Nieuwlaat R, Pisters R, et al.- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 2010, 137, 263-272.
Beigel R, Wunderlich NC, Ho SY, et al.- The left atrial appendage: Anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging, 2014, 7, 1251-1265.
Wang Y, Di Biase L, Horton RP, et al.- Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol, 2010, 21, 973-982.
Su P, McCarthy KP, Ho SY.- Occluding the left atrial appendage: anatomical considerations. Heart, 2008, 94, 1166-1170.
Madden JL.- Resection of the left auricular appendix. J Am Med Assoc, 1949, 140, 769-772.
Bartus K, Han FT, Bednarek J, et al.- Percutaneous left atrial appendage suture ligation using the lariat device in patients with atrial fibrillation: Initial clinical experience. J Am Coll Cardiol, 2013, 62, 108-118.
Lempereur M, Aminian A, Dulgheru R, et al.-Role of imaging in left atrial appendage occlusion. Int J Cardiovasc Pract, 2017, 2, 4-14.
Ahrens I, Lip GY, Peter K.- What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? Thromb Haemost, 2011, 105, 574-578.
Lempereur M, Legrand V, Lancellotti P.- Contribution to the study of percutaneous left atrial appendage occlusion, 2017, Thèse de Doctorat.
Holmes DR, Reddy VY, Turi ZG, et al.- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet, 2009, 374, 534-542.
Holmes Jr. DR, Kar S, Price MJ, et al.- Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol, 2014, 64, 1-12.
Reddy VY, Doshi SK, Kar S, et al.- 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol, 2017, 70, 2964-2975.
Boersma L V., Ince H, Kische S, et al.- Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm, 2017, 14, 1302-1308
Tzikas A, Shakir S, Gafoor S, et al.- Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention, 2016, 11, 1170-1179.
Landmesser U, Schmidt B, Nielsen-Kudsk JE, et al.- Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. EuroIntervention, 2017, 13, 867-876.
Landmesser U, Tondo C, Camm J, et al.- Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. EuroIntervention, 2018, 14, e590-e597
De Backer O, Arnous S, Ihlemann N, et al.-Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update. Open Heart, 2014, 1, e000020.
Reddy VY, Mobius-Winkler S, Miller MA, et al.-Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol, 2013, 61, 2551-2556.
